Katsuya Nakamura

Katsuya Nakamura

Auto-generated profile, based on publicly available information

Katsuya Nakamura

Department of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2019 in Neuron
Verified
Journal Article
Closed access
LNLien Nguyen
Lien Nguyen
FMFabio Montrasio
Fabio Montrasio
APAmrutha Pattamatta
Amrutha Pattamatta
STSolaleh Khoramian Tusi
Solaleh Khoramian Tusi
OBOlgert Bardhi
Olgert Bardhi
LRLaura P.W. Ranum
Laura P.W. Ranum

6 August 2015 in Cerebellum & Ataxias
Verified
Journal Article
Open access
PDF file
AMAkira Matsushima
Akira Matsushima
KYKunihiro Yoshida
Kunihiro Yoshida
HGHirokazu Genno
Hirokazu Genno
AMAsuka Murata
Asuka Murata
SMSetsuko Matsuzawa
Setsuko Matsuzawa
SIShu-Ichi Ikeda
Shu-Ichi Ikeda
The aim of this study was to investigate the usefulness of a triaxial accelerometer for the clinical assessment of standing and gait impairment in ataxic patients quantitatively. Fifty-one patients with spinocerebellar ataxia (SCA) or multiple system atrophy with predominant cerebellar ataxia (MSA-C) and 56 healthy control subjects were enrolled. The subjects, with a triaxial accelerometer on their back, were indicated to stand for 30 s in four different conditions (eyes opened or closed, and feet apart or together) and then to walk 10 m for a total of 12 times on a flat floor at their usual walking speed. In standing analysis, the degree of body sway was assessed. In gait analysis, gait velocity, cadence, step length, step regularity (auto-correlation coefficient: AC), step repeatability (cross-correlation coefficient) and the degree of body sway (The ratio of root mean square in each direction to the root mean square vector magnitude: RMSR) were evaluated. The degree of body sway in each standing condition and all parameters in gait showed a significant difference between the patients and control subjects. The AC and RMSR values, as well as the Scale for the Assessment and Rating of Ataxia score, showed a strong correlation with disease duration. Various parameters obtained by a triaxial accelerometer can be sensitive and objective markers for the assessment and follow-up of standing and gait impairment in ataxic patients.

1 October 2010 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
KNKatsuya Nakamura
Katsuya Nakamura
KYKunihiro Yoshida
Kunihiro Yoshida
TYTsuneaki Yoshinaga
Tsuneaki Yoshinaga
MKMinori Kodaira
Minori Kodaira
YSYasuhiro Shimojima
Yasuhiro Shimojima
SIShu-Ichi Ikeda
Shu-Ichi Ikeda

12 February 2014 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Closed access
PDF file
HSHaruo Shimazaki
Haruo Shimazaki
JHJunko Honda
Junko Honda
TNTametou Naoi
Tametou Naoi
MNMichito Namekawa
Michito Namekawa
INImaharu Nakano
Imaharu Nakano
YTYoshihisa Takiyama
Yoshihisa Takiyama
Background Autosomal-recessive hereditary spastic paraplegias (AR-HSP) consist of a genetically diverse group of neurodegenerative diseases characterised by pyramidal tracts dysfunction. The causative genes for many types of AR-HSP remain elusive. We tried to identify the gene mutation for AR-HSP with cerebellar ataxia and neuropathy. Methods This study included two patients in a Japanese family with their parents who are first cousins. Neurological examination and gene analysis were conducted in the two patients and two normal family members. We undertook genome-wide linkage analysis employing single nucleotide polymorphism arrays using the two patients’ DNAs and exome sequencing using one patient's sample. Results We detected a homozygous missense mutation (c.4189T>G, p.F1397V) in the lysosomal trafficking regulator (LYST) gene, which is described as the causative gene for Chédiak–Higashi syndrome (CHS). CHS is a rare autosomal-recessive syndrome characterised by hypopigmentation, severe immune deficiency, a bleeding tendency and progressive neurological dysfunction. This mutation was co-segregated with the disease in the family and was located at well-conserved amino acid. This LYST mutation was not found in 200 Japanese control DNAs. Microscopic observation of peripheral blood in the two patients disclosed large peroxidase-positive granules in both patients’ granulocytes, although they had no symptoms of immune deficiency or bleeding tendency. Conclusions We diagnosed these patients as having adult CHS presenting spastic paraplegia with cerebellar ataxia and neuropathy. The clinical spectrum of CHS is broader than previously recognised. Adult CHS must be considered in the differential diagnosis of AR-HSP.

1 March 2009 in Journal of the Neurological Sciences
Verified
Journal Article
Open access
KNKatsuya Nakamura
Katsuya Nakamura
KYKunihiro Yoshida
Kunihiro Yoshida
DMDaigo Miyazaki
Daigo Miyazaki
HMHiroshi Morita
Hiroshi Morita
SIShu-Ichi Ikeda
Shu-Ichi Ikeda
The clinical effect of the GABAergic drug gabapentin was evaluated in 11 patients with spinocerebellar ataxia type 6 (SCA6). The total period of gabapentin treatment was 4 weeks, and outcome measures were determined with the International Cooperative Ataxia Rating Scales (ICARS) and postural sway studies. At week 4, 5 patients showed a decrease of the ICARS values by more than 10% compared with the pre-treatment baseline. Eight patients showed a more than 10% decrease of the sway area (SA) and/or sway path length (SPL) values in postural sway studies. The ICARS values and SA/SPL values were not necessarily consistent in each patient, but 3 patients showed a more than 10% decrease in the ICRAS, SA, and SPL values at week 4 when compared to the pre-treatment baseline. As a whole, the efficacy of gabapentin was not statistically confirmed in the 4-week trial because of the variation in efficacy in each patient, but the data are indicative that some SCA6 patients could benefit from gabapentin treatment.

9 November 2016 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
KNKatsuya Nakamura
Katsuya Nakamura
KYKunihiro Yoshida
Kunihiro Yoshida
AMAkira Matsushima
Akira Matsushima
YSYusaku Shimizu
Yusaku Shimizu
SSShunichi Sato
Shunichi Sato
SIShu-Ichi Ikeda
Shu-Ichi Ikeda